Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 287193-01-5 | MDL No. : | MFCD17016080 |
Formula : | C10H15NO2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UENGYBYGCXKNRF-UHFFFAOYSA-N |
M.W : | 181.23 | Pubchem ID : | 54349237 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.7 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 54.75 |
TPSA : | 29.54 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.52 cm/s |
Log Po/w (iLOGP) : | 2.79 |
Log Po/w (XLOGP3) : | 1.25 |
Log Po/w (WLOGP) : | 1.19 |
Log Po/w (MLOGP) : | 1.61 |
Log Po/w (SILICOS-IT) : | 1.14 |
Consensus Log Po/w : | 1.59 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.55 |
Solubility : | 5.07 mg/ml ; 0.028 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.47 |
Solubility : | 6.16 mg/ml ; 0.034 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.8 |
Solubility : | 28.9 mg/ml ; 0.159 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.42 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | With potassium carbonate In methanol at 0℃; for 3 h; | To a stirringsolution of aldehyde1.3 (5 g, 27 mmol) in MeOH (70 ml)at ooc was added the Bestmannreagent (6 g, 31.2 mmol), followed by potassium carbonate(14.92 g, 108mmol) and the reaction was stirred for 3 hr. The reaction mixture was then diluted with EtOAc 5 (150 ml), filtered and concentrated under reduced pressureto give a crude, which was purified by flash chromatography (silicagel/ 0-100percent EtOAc in hexanes)to yield compound1.4 (4.6 g,94percent).1H NMR {400 MHz, DMSO-d6)o 1.34 (s, 9 H), 3.22-3.23(m, 1 H), 3.34-3.39 (m, 1 H), 3.68 (t, J = 6.8, 2 H), 4.04 (t, J = 8.4 Hz, 2 H). |
94% | With potassium carbonate In methanol at 0℃; for 3 h; | To a solution of tert-butyl 3-formylazetidine-l-carboxylate (5.0 g, 27 mmol) in MeOH (70 mL) at 0 °C was added dimethyl (l-diazo-2-oxopropyl)phosphonate (6.0 g, 31 mmol), followed by potassium carbonate (14.9 g, 108 mmol) and the reaction was stirred for 3 hr. The reaction mixture was then diluted with EtOAc (150 mL), filtered and concentrated under reduced pressure. The residue was purified by flash chromatography (0 -100 percent EtOAc in hexanes) to give the title compound (4.6 g, 94percent). XH NMR (400 MHz, DMSO-d6) δ 4.04 (t, J = 8.4 Hz, 2 H), 3.68 (t, J= 6.8, 2 H), 3.34-3.39 (m, 1 H), 3.22-3.23 (m, 1 H), 1.34 (s, 9 H). |
87% | With potassium carbonate In methanol at 0℃; for 4 h; | Step 1: Synthesis of tert-butyl 3-ethynylazetidine-1-carboxylate A solution of tert-butyl 3-formylazetidine-1-carboxylate (7 g, 1 eq) in MeOH (378 ml) was cooled at 0° C. K2CO3(10.5 g, 2 eq), dimethyl (1-diazo-2-oxopropyl)phosphonate (15.8 g, 2.2 eq) was added. The mixture was stirred for 4 hr at 0° C., and extracted with dichloromethane and water. The organic layer was washed with sat. aq. NH4Cl, dried over anhydrous MgSO4 and concentrated in vacuo. The residue was purified with column chromatography to prepare the title compound (5.95 g, 87percent). 1H NMR (600 MHz, CDCl3-d1); δ4.10-4.07 (m, 2H), 3.90-3.87 (m, 2H), 3.27-3.24 (m, 1H), 2.26-2.25 (m, 1H), 1.39 (s, 9H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | Stage #1: With sodium azide; caesium carbonate; methanesulfonyl chloride In acetonitrile at 0 - 20℃; for 3 h; Stage #2: With caesium carbonate In methanol; acetonitrile at 0℃; |
Sodium azide (2.4 g, 37 mmol) is suspended in ACN (14 mL) and methanesulfonyl chloride (2.7 mL, 35 mmol) is added over 45 seconds. The resulting mixture is stirred overnight at room temperature and is then cooled to 0 °C, at which point dimethyl (2-oxopropyi)phosphonate (4.3 mL, 31 mrnoi) is added over 30 seconds followed by Cs2CO3 (11 g, 34 mniol). This mixture is stirred for 30 minutes at 0 °C andthen at room temperature for 2.5 hours. The mixture is recooled to 0 °C and MeOH (15.5 mL) is added. After 1 hour, tert-butyl 3-fhmiyiazetidine- I -carboxylate (3.0 g, 16 mmol)added followed by additional Cs2CO3 (9.1 g, 28 mmol), and 25 minutes later the ice-water bath is removed and the reaction is stirred overnight. The solvent is removed under vacuum to give an orange oil that is purified by silica gel chromatography using 50percent MTBE/hexanes, The title compound is obtained as a light yellow oil (2.68 g, 93percent). MS (mlz): 181 (M±H). |
[ 149990-27-2 ]
tert-Butyl but-3-yn-1-ylcarbamate
Similarity: 0.85
[ 1363383-17-8 ]
tert-Butyl 4-ethynyl-4-methylpiperidine-1-carboxylate
Similarity: 0.81
[ 287192-97-6 ]
tert-Butyl 4-ethynylpiperidine-1-carboxylate
Similarity: 0.81
[ 325775-44-8 ]
tert-Butyl 3-(aminomethyl)azetidine-1-carboxylate
Similarity: 0.87
[ 147621-21-4 ]
tert-Butyl azetidine-1-carboxylate
Similarity: 0.87
[ 1173206-71-7 ]
tert-Butyl 3-(aminomethyl)azetidine-1-carboxylate hydrochloride
Similarity: 0.85
[ 325775-44-8 ]
tert-Butyl 3-(aminomethyl)azetidine-1-carboxylate
Similarity: 0.87
[ 147621-21-4 ]
tert-Butyl azetidine-1-carboxylate
Similarity: 0.87
[ 1173206-71-7 ]
tert-Butyl 3-(aminomethyl)azetidine-1-carboxylate hydrochloride
Similarity: 0.85
[ 325775-44-8 ]
tert-Butyl 3-(aminomethyl)azetidine-1-carboxylate
Similarity: 0.87
[ 147621-21-4 ]
tert-Butyl azetidine-1-carboxylate
Similarity: 0.87
[ 1173206-71-7 ]
tert-Butyl 3-(aminomethyl)azetidine-1-carboxylate hydrochloride
Similarity: 0.85
[ 1104083-23-9 ]
tert-Butyl 3-hydroxy-3-methylazetidine-1-carboxylate
Similarity: 0.84